Found 11 matching trials
A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM) PHASE1 The purpose of this study is to assess the safety and tolerability, maximum...
Show More Location
City of Hope - Duarte
Learn More & Join Trial
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants PHASE1 The purpose of this study is to characterize the pharmacokinetic and safety...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant PHASE2 Antibody-mediated rejection (AMR) is a major cause of worsening kidney func...
Show More Location
Multiple Locations
Learn More & Join Trial
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia PHASE3 Primary immune thrombocytopenia (ITP) is a condition where the immune syste...
Show More Location
Genesis Cancer and Blood Institute - SCRI
Learn More & Join Trial
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) PHASE1 The purpose of this study is to evaluate the safety and tolerability of TAK...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
A Study of TAK-079 in People With Generalized Myasthenia Gravis PHASE2 Myasthenia gravis is an autoimmune condition that causes muscle weakness. A...
Show More Location
The University of Arizona Medical Center
Learn More & Join Trial
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia PHASE3 Primary immune thrombocytopenia (ITP) is a condition where the immune syste...
Show More Location
Genesis Cancer and Blood Institute - SCRI
Learn More & Join Trial
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy PHASE3 Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when ...
Show More Location
UAB Nephrology Research Clinic at Paula Building
Learn More & Join Trial
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy PHASE1 This study will have two parts. The main aims are to:
* check the side eff...
Show More Location
Amicis Research Center - Northridge - Nordhoff
Learn More & Join Trial
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) PHASE1 The purpose of this original study is to determine the recommended phase 2 ...
Show More Learn More & Join Trial